Tenderwize
Back to tender search

Pharmaceutical products with active substance Tolvaptan

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Jun 29, 2027 · 316 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Tolvaptan (ATC: G04BX21 - ausgenommen Arzneimittel mit einheitlichen Wirkstärken)

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

No guaranteed minimum volume or estimated value; the tender does not provide any indication of potential revenue.

Contracts may be terminated if the buyer later awards exclusive contracts for the same active substance.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Non-exclusive discount agreements for Tolvaptan (ATC G04BX21) finished medicinal products
  • Open-house model: any qualified pharmaceutical company can join
Show full summary

This is an open-house model for non-exclusive discount agreements for Tolvaptan (ATC G04BX21) in Germany, administered by AOK Sachsen-Anhalt. It is not a typical public procurement but a transparent process for any qualified pharmaceutical company to join a discount agreement under §130a Abs. 8 SGB V. The contract duration is 24 months (01.09.2025 to 31.08.2027). No estimated value is provided. Documents are available but not analyzed. Submission is possible via platform (with QES) or postal mail.

Risks

No guaranteed minimum volume or estimated value; the tender does not provide any indication of potential revenue.

Contracts may be terminated if the buyer later awards exclusive contracts for the same active substance.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Administrative

  • Pharmaceutical companies must request and complete the participation documents
  • Documents must be fully completed and signed
  • Submission via platform with qualified electronic signature or postal mail

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria; all qualified participants receive a contract.

Buyer

Location

Magdeburg, DEU

Buyer profile

Open profile

Identifier

DE258393558

Activity

Health

Lots (1)

LOT-0001

Pharmaceutical products with active substance Tolvaptan

Non-exclusive discount agreements for finished medicinal products containing Tolvaptan (ATC G04BX21, excluding uniform strengths). Open-house model with no exclusivity, individual negotiations, or minimum volume. Contract duration 24 months starting 01.09.2025, ending 31.08.2027. Early termination possible if exclusive contracts are awarded.

SuppliesEU fundedElectronic submission

Location

DEE03, Germany

Duration

2 YEAR

Category

Pharmaceutical products

Award Criteria

No award criteria; all qualified participants receive a contract.

Deadline

Deadline Jun 30, 2027

Procurement Details

Publication date
13 Jul 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
457338-2025

Documents (1)

Similar tenders